TY  - RPRT
TI  - Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer
AU  - Heyrim Cho
AU  - Zuping Wang
AU  - Doron Levy
PY  - 2020
DO  - 10.1016/j.jtbi.2020.110403
UR  - https://arxiv.org/abs/2001.10573
ID  - 2001.10573
ER  -